Enhancing Single‐Domain Antibody‐Based Protein Degradation for Synucleinopathies

Yixiang Jiang · 2025

Read Enhancing Single‐Domain Antibody‐Based Protein Degradation for Synucleinopathies by Yixiang Jiang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710823.txt.

Description

Yixiang Jiang reports a 2025 mouse study of a small antibody tool against alpha-synuclein, the protein that clumps in Parkinson's-like diseases. Full antibodies are too large to enter the brain well. Single-domain antibodies are ten times smaller and reach the brain far better. Jiang's team had built such a tool, called 2D8, that binds the protein.

The team linked 2D8 to a drug tag, making a version that sends the protein to the cell's shredder. In cell tests the new version cleared the protein and blocked its toxic effect. In mice, three doses cut the brain signal of the protein by about four fifths, far more than the plain tool. Lab checks confirmed deep clearance with no clear harm.

Catalog record

CREATORYixiang Jiang
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11710823

Browse the full library · About the Tower of Babel